Attached files
| file | filename |
|---|---|
| 10-K - 10-K - AMAG PHARMACEUTICALS, INC. | a2223053z10-k.htm |
| EX-21.1 - EX-21.1 - AMAG PHARMACEUTICALS, INC. | a2223053zex-21_1.htm |
| EX-23.1 - EX-23.1 - AMAG PHARMACEUTICALS, INC. | a2223053zex-23_1.htm |
| EX-31.1 - EX-31.1 - AMAG PHARMACEUTICALS, INC. | a2223053zex-31_1.htm |
| EX-10.6 - EX-10.6 - AMAG PHARMACEUTICALS, INC. | a2223053zex-10_6.htm |
| EX-31.2 - EX-31.2 - AMAG PHARMACEUTICALS, INC. | a2223053zex-31_2.htm |
| EX-10.19 - EX-10.19 - AMAG PHARMACEUTICALS, INC. | a2223053zex-10_19.htm |
| EX-10.31 - EX-10.31 - AMAG PHARMACEUTICALS, INC. | a2223053zex-10_31.htm |
| EX-10.32 - EX-10.32 - AMAG PHARMACEUTICALS, INC. | a2223053zex-10_32.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AMAG PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-32.2 - EX-32.2 - AMAG PHARMACEUTICALS, INC. | a2223053zex-32_2.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of AMAG Pharmaceuticals, Inc. (the "Company") on Form 10-K for the period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William K. Heiden, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
- (1)
- The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
- (2)
- The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /s/ WILLIAM K. HEIDEN William K. Heiden President and Chief Executive Officer (principal executive officer) |
||
Dated: February 17, 2015 |
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002